Deep Track Capital, LP - Q4 2020 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q4 2020
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
JAZZ PHARMACEUTICALS PLC8Q3 20237.2%
TRAVERE THERAPEUTICS INC8Q3 20235.7%
IMMUNOVANT INC8Q3 20237.2%
BICYCLE THERAPEUTICS PLC8Q3 20235.2%
BEAM THERAPEUTICS INC8Q3 20233.9%
4D MOLECULAR THERAPEUTICS IN8Q3 20232.9%
REPARE THERAPEUTICS INC8Q3 20233.1%
VIRIDIAN THERAPEUTICS INC8Q3 20232.2%
DYNE THERAPEUTICS INC8Q3 20232.2%
SILENCE THERAPEUTICS PLC8Q3 20231.6%

View Deep Track Capital, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Deep Track Capital, LP Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Orchard Therapeutics plcMarch 20, 202319,125,15010.0%
ARDELYX, INC.Sold outFebruary 14, 202300.0%
ASSEMBLY BIOSCIENCES, INC.February 14, 20231,833,4373.8%
Aurinia Pharmaceuticals Inc.February 14, 2023324,2380.2%
CHINOOK THERAPEUTICS, INC.February 14, 20233,000,0004.7%
Forma Therapeutics Holdings, Inc.Sold outFebruary 14, 202300.0%
Global Blood Therapeutics, Inc.Sold outFebruary 14, 202300.0%
HOOKIPA Pharma Inc.February 14, 20231,240,3692.4%
KalVista Pharmaceuticals, Inc.Sold outFebruary 14, 202300.0%
Keros Therapeutics, Inc.Sold outFebruary 14, 202300.0%

View Deep Track Capital, LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-26
SC 13G2024-04-26
SC 13G/A2024-04-22
SC 13G2024-04-12
SC 13G2024-04-05
SC 13G2024-03-22
SC 13G2024-03-22
SC 13G2024-03-22
SC 13G2024-03-15
32024-03-14

View Deep Track Capital, LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Deep Track Capital, LP's holdings

CSVXLS